Cite
Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
MLA
Spallanzani, Raúl Germán, et al. “Expansion of CD11b(+)Ly6G (+)Ly6C (Int) Cells Driven by Medroxyprogesterone Acetate in Mice Bearing Breast Tumors Restrains NK Cell Effector Functions.” Cancer Immunology, Immunotherapy : CII, vol. 62, no. 12, Dec. 2013, pp. 1781–95. EBSCOhost, https://doi.org/10.1007/s00262-013-1483-x.
APA
Spallanzani, R. G., Dalotto-Moreno, T., Raffo Iraolagoitia, X. L., Ziblat, A., Domaica, C. I., Avila, D. E., Rossi, L. E., Fuertes, M. B., Battistone, M. A., Rabinovich, G. A., Salatino, M., & Zwirner, N. W. (2013). Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions. Cancer Immunology, Immunotherapy : CII, 62(12), 1781–1795. https://doi.org/10.1007/s00262-013-1483-x
Chicago
Spallanzani, Raúl Germán, Tomás Dalotto-Moreno, Ximena Lucía Raffo Iraolagoitia, Andrea Ziblat, Carolina Inés Domaica, Damián Ezequiel Avila, Lucas Ezequiel Rossi, et al. 2013. “Expansion of CD11b(+)Ly6G (+)Ly6C (Int) Cells Driven by Medroxyprogesterone Acetate in Mice Bearing Breast Tumors Restrains NK Cell Effector Functions.” Cancer Immunology, Immunotherapy : CII 62 (12): 1781–95. doi:10.1007/s00262-013-1483-x.